AI assistant
GlaxoSmithKline PLC — Remuneration Information 2017
Nov 9, 2017
5262_rns_2017-11-09_75719c14-0f95-48f2-88da-d711521ee874.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1021W
GlaxoSmithKline PLC
09 November 2017
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline Share Option Plan - Ordinary Shares | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 4,104,101 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 543,609 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 3,559,772 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline Share Option Plan - ADS | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 8,795,814 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 611,414 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 8,185,120 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | Glaxo Wellcome UK Share Option Scheme | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 5,119,750 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 5,119,750 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | Glaxo Wellcome International Share Option Scheme | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 13,267,156 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 13,267,156 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | Glaxo Wellcome 1999 Share Option Plan | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 1,040,000 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1,040,000 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 163,606 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 163,606 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 275,420 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 275,420 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 100,000 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 100,000 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline plc Share Save Plan 2012 | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 1,635,325 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 93,255 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1,542,070 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 09 November 2017
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan | |||
| Period of return: | From: | 1 May 2017 | To: | 31 October 2017 |
| Balance of unallotted securities under scheme(s) from previous return: | 200,071 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 989 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 199,082 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRKMMGMVLLGNZM